Patent directory · USPTO A61K / A61P
Patents matching “inhibitor”
2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10858323
HDAC inhibitors for the treatment of diabetic peripheral neuropathy
granted -
US 10857137
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10858338
Inhibitors for soluble epoxide hydrolase (SEH) and fatty acid amide hydrolase (FAAH)
granted -
US 10857148
Methods for the administration of certain VMAT2 inhibitors
granted -
US 10851102
Imidazole and triazole containing bicyclic compounds as JAK inhibitors
granted -
US 10851110
Heterocyclic inhibitors of PTPN11
granted -
US 10851072
Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of the same
granted -
US 10851115
Heterocyclic compounds as RSV inhibitors
granted -
US 10851093
Tyrosine kinase inhibitors
granted -
US 10851058
Histone deacetylase inhibitors
granted -
US 10845366
Predictive markers for polyamine inhibitor cancer therapies
granted -
US 10842791
Small molecule inhibitors of EGFR and PI3K
granted -
US 10842800
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
granted -
US 10844376
Structurally-enhanced miRNA inhibitor S-TuD
granted -
US 10836763
5 to 7 membered heterocyclic amides as JAK inhibitors
granted -
US 10836759
Thiazole derivatives useful as mutant IDH1 inhibitors for treating cancer
granted -
US 10836741
Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
granted -
US 10836772
DNA polymerase IIIC inhibitors and use thereof
granted -
US 10836789
Inhibitors of glucocorticoid receptor
granted -
US 10836720
Inhibitors of integrin alpha 5 beta 1 and methods of use
granted -
US 10829461
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
granted -
US 10829438
Neprilysin inhibitors
granted -
US 10829485
ATF6 inhibitors and uses thereof
granted -
US 10829488
N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors
granted